Anti-Dibcausing hemolytic disease of the fetus and newborn and the challenges of anti-Dibin perinatal management in China-Reference-Cited by-同舟云学术

Anti-Dibcausing hemolytic disease of the fetus and newborn and the challenges of anti-Dibin perinatal management in China

Published:2015-11-17 Issue:6 Volume:25 Page:428-430
ISSN:0958-7578
Container-title:Transfusion Medicine
language:en
Short-container-title:Transfusion Med

Author:

Wu Y.¹²,Fan L.¹,Liu M.³,Shen W.¹,Xiang D.¹,Cai X.¹⁴

Affiliation:

1. Blood Group Reference Laboratory, Shanghai Institute of Blood Transfusion; Shanghai Blood Center; Shanghai China

2. Blood Group Reference Laboratory; Taiyuan Red Cross Blood Center; Taiyuan China

3. Children's Hospital of Fudan University, Blood Transfusion Department; Shanghai China

4. Blood Transfusion Department; Ruijin Hospital, Medical School of Shanghai Jiao Tong University; Shanghai China

Funder

National Natural Science Foundation of China

Young Medical Talents Training Program of Shanghai Municipal Public Health Bureau

2014 Morningstar Young Scholars Program of Shanghai Jiao Tong University

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tme.12260/fullpdf

Reference12 articles.

1. Choice of blood for exchange transfusion;Allen;Transfusion,1966

2. Band 3 Memphis variant II. Altered stilbene disulfonate binding and the Diego (Dia) blood group antigen are associated with the human erythrocyte band 3 mutation Pro854Leu;Bruce;Journal of Biological Chemistry,1994

3. Molecular genetic analysis for the B subgroup revealing two novel alleles in the ABO gene;Cai;Transfusion,2008

4. Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn;Gottstein;Archives of Disease in Childhood - Fetal and Neonatal Edition,2003